Extendicare Inc. ("Extendicare" or the "Company") announced today the successful closing of its previously announced offering (the "Offering") of $450 million aggregate principal amount of 4.345% ...
Spiral Therapeutics, Inc. ("Spiral Therapeutics" or "Spiral"), a clinical-stage company developing novel therapies for inner ear disorders, today announced the closing of its $27 million Series B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results